Harper L - Search Results

1

The complications of vasculitis and its treatment.

King C, Harper L, Little M. King C, et al. Among authors: harper l. Best Pract Res Clin Rheumatol. 2018 Feb;32(1):125-136. doi: 10.1016/j.berh.2018.07.009. Epub 2018 Aug 28. Best Pract Res Clin Rheumatol. 2018. PMID: 30526892 Review.

2

ABC of arterial and vascular disease: vasculitis.

Savage CO, Harper L, Cockwell P, Adu D, Howie AJ. Savage CO, et al. Among authors: harper l. BMJ. 2000 May 13;320(7245):1325-8. doi: 10.1136/bmj.320.7245.1325. BMJ. 2000. PMID: 10807632 Free PMC article. Review. No abstract available.

3

Adjuvant treatment of patients with antineutrophil cytoplasmic antibody-associated vasculitis with vitamins E and C reduces superoxide production by neutrophils.

Harper L, Nuttall SL, Martin U, Savage CO. Harper L, et al. Rheumatology (Oxford). 2002 Mar;41(3):274-8. doi: 10.1093/rheumatology/41.3.274. Rheumatology (Oxford). 2002. PMID: 11934963 Clinical Trial.

4

Malignancy is increased in ANCA-associated vasculitis.

Pankhurst T, Savage CO, Gordon C, Harper L. Pankhurst T, et al. Among authors: harper l. Rheumatology (Oxford). 2004 Dec;43(12):1532-5. doi: 10.1093/rheumatology/keh374. Epub 2004 Aug 17. Rheumatology (Oxford). 2004. PMID: 15316126

5

ANCA-associated renal vasculitis at the end of the twentieth century--a disease of older patients.

Harper L, Savage CO. Harper L, et al. Rheumatology (Oxford). 2005 Apr;44(4):495-501. doi: 10.1093/rheumatology/keh522. Epub 2004 Dec 21. Rheumatology (Oxford). 2005. PMID: 15613403

6

ANCA-associated vasculitis: new options beyond steroids and cytotoxic drugs.

Selamet U, Kovaliv YB, Savage CO, Harper L. Selamet U, et al. Among authors: harper l. Expert Opin Investig Drugs. 2007 May;16(5):689-703. doi: 10.1517/13543784.16.5.689. Expert Opin Investig Drugs. 2007. PMID: 17461741 Review.

7

ANCA-associated vasculitis: from bench research to novel treatments.

Pallan L, Savage CO, Harper L. Pallan L, et al. Among authors: harper l. Nat Rev Nephrol. 2009 May;5(5):278-86. doi: 10.1038/nrneph.2009.45. Nat Rev Nephrol. 2009. PMID: 19384329 Review.

8

Adverse effects of therapy for ANCA-associated vasculitis.

Turnbull J, Harper L. Turnbull J, et al. Among authors: harper l. Best Pract Res Clin Rheumatol. 2009 Jun;23(3):391-401. doi: 10.1016/j.berh.2009.04.002. Best Pract Res Clin Rheumatol. 2009. PMID: 19508946 Review.

9

Early mortality in systemic vasculitis: relative contribution of adverse events and active vasculitis.

Little MA, Nightingale P, Verburgh CA, Hauser T, De Groot K, Savage C, Jayne D, Harper L; European Vasculitis Study (EUVAS) Group. Little MA, et al. Among authors: harper l. Ann Rheum Dis. 2010 Jun;69(6):1036-43. doi: 10.1136/ard.2009.109389. Epub 2009 Jul 1. Ann Rheum Dis. 2010. PMID: 19574233

10

Renal transplantation in systemic vasculitis: when is it safe?

Little MA, Hassan B, Jacques S, Game D, Salisbury E, Courtney AE, Brown C, Salama AD, Harper L. Little MA, et al. Among authors: harper l. Nephrol Dial Transplant. 2009 Oct;24(10):3219-25. doi: 10.1093/ndt/gfp347. Epub 2009 Jul 13. Nephrol Dial Transplant. 2009. PMID: 19602476

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

934 results

Search Page